Overexpression of PDK3 in tumor cells (HeLa, IMR32, and colo320DM cells) can increase metabolic conversion to glycolysis and increase the risk of drug resistance and tumor recurrence (Lu et al., 2008). The gene discussed is PDK3; the disease is neoplasm.